These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 39192398

  • 1. [Correlation Analysis between Serum Fibronectin 3 Levels and Early Severe Bleeding in Patients with Newly Diagnosed Acute Promyelocytic Leukemia].
    Zhao HB, Qiao JJ, He XH.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Aug; 32(4):1058-1062. PubMed ID: 39192398
    [Abstract] [Full Text] [Related]

  • 2. Value of the FDP/FIB ratio in predicting early severe bleeding events in patients with newly diagnosed acute promyelocytic leukemia.
    Li S, Gao Y, Li F, Zheng Y, Su Y.
    Ann Hematol; 2023 Apr; 102(4):787-794. PubMed ID: 36750485
    [Abstract] [Full Text] [Related]

  • 3. [Correlation between D-Dimer/Fibrinogen Ratio and Bleeding in Patients with Newly Diagnosed Acute Promyelocytic Leukemia].
    Li SS, Yang XW, Zheng Y, Gao YJ, Su YH.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Oct; 31(5):1340-1344. PubMed ID: 37846682
    [Abstract] [Full Text] [Related]

  • 4. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z, Cholovitsh M, Elezovitsh I, Vidovitsh A, Radoshevitsh-Radojkovitsh N, Boshkovitsh D, Novak A, Basara N.
    Srp Arh Celok Lek; 1995 Oct; 123(11-12):279-85. PubMed ID: 16296239
    [Abstract] [Full Text] [Related]

  • 5. [Analysis of empirical treatment for newly diagnosed acute promyelocytic leukemia combined with disseminated intravascular coagulation].
    Yang H, Zhu CY, Wang QS, Niu JH, Zhang Q, Zhu HY, Yao ZL, Xu YY, Jing Y, Yu L.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):315-22. PubMed ID: 24762998
    [Abstract] [Full Text] [Related]

  • 6. Low platelet count is potentially the most important contributor to severe bleeding in patients newly diagnosed with acute promyelocytic leukemia.
    Song YH, Peng P, Qiao C, Zhang R, Li JY, Lu H.
    Onco Targets Ther; 2017 Apr; 10():4917-4924. PubMed ID: 29062237
    [Abstract] [Full Text] [Related]

  • 7. Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group.
    Adès L, Thomas X, Bresler AG, Raffoux E, Spertini O, Vey N, Marchand T, Récher C, Pigneux A, Girault S, Deconinck E, Gardin C, Tournilhac O, Lambert JF, Chevallier P, de Botton S, Lejeune J, Dombret H, Chevret S, Fenaux P.
    Haematologica; 2018 Dec; 103(12):2033-2039. PubMed ID: 30026341
    [Abstract] [Full Text] [Related]

  • 8. Influence of cytokines on early death and coagulopathy in newly diagnosed patients with acute promyelocytic leukemia.
    Zhao S, Ge Y, Li Z, Yang T.
    Front Immunol; 2023 Dec; 14():1100151. PubMed ID: 37063881
    [Abstract] [Full Text] [Related]

  • 9. [Effects of Cytokines on Early Death in Patients with Newly Diagnosed Acute Promyelocytic Leukemia].
    Zhao SX, Ge YY, Li ZZ, He HP, Shen CM, Shi KQ, Yang TH, DU YY.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Oct; 31(5):1315-1321. PubMed ID: 37846678
    [Abstract] [Full Text] [Related]

  • 10. Effects of peripheral blood leukocyte count and tumor necrosis factor-alpha on early death in acute promyelocytic leukemia.
    Wen J, Xu F, Zhou Q, Shi L, Liu Y, Yue J, Zhang Y, Liang X.
    BMC Cancer; 2023 Jan 07; 23(1):27. PubMed ID: 36611025
    [Abstract] [Full Text] [Related]

  • 11. Management and treatment results in patients with acute promyelocytic leukaemia (APL) not enrolled in clinical trials.
    Micol JB, Raffoux E, Boissel N, Lengliné E, Canet E, Daniel MT, Labarthe Ad, Maarek O, Cassinat B, Adès L, Baruchel A, Degos L, Azoulay E, Dombret H.
    Eur J Cancer; 2014 Apr 07; 50(6):1159-68. PubMed ID: 24440088
    [Abstract] [Full Text] [Related]

  • 12. Assessment of Arsenic Trioxide and All-trans Retinoic Acid for the Treatment of Pediatric Acute Promyelocytic Leukemia: A Report From the Children's Oncology Group AAML1331 Trial.
    Kutny MA, Alonzo TA, Abla O, Rajpurkar M, Gerbing RB, Wang YC, Hirsch BA, Raimondi S, Kahwash S, Hardy KK, Hardy S, Meshinchi S, Gamis AS, Kolb EA, Feusner JH, Gregory J.
    JAMA Oncol; 2022 Jan 01; 8(1):79-87. PubMed ID: 34762093
    [Abstract] [Full Text] [Related]

  • 13. miR-638 in circulating leukaemia cells as a non-invasive biomarker in diagnosis, treatment response and MRD surveillance of acute promyelocytic leukaemia.
    Bai Y, Chen C, Guo X, Ding T, Yang X, Yu J, Yang J, Ruan J, Zheng X, Chen Z.
    Cancer Biomark; 2020 Jan 01; 29(1):125-137. PubMed ID: 32568176
    [Abstract] [Full Text] [Related]

  • 14. Predictive factors for differentiating thrombohemorrhagic disorders in high-risk acute promyelocytic leukemia.
    Xiao M, Zhou P, Liu Y, Wei S, Li D, Li W, Niu X, Niu J, Zhang Y, Cao W, Liu B, Wang X, Bai Y, Sun K.
    Thromb Res; 2022 Feb 01; 210():33-41. PubMed ID: 34998209
    [Abstract] [Full Text] [Related]

  • 15. Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group.
    De Botton S, Dombret H, Sanz M, Miguel JS, Caillot D, Zittoun R, Gardembas M, Stamatoulas A, Condé E, Guerci A, Gardin C, Geiser K, Makhoul DC, Reman O, de la Serna J, Lefrere F, Chomienne C, Chastang C, Degos L, Fenaux P.
    Blood; 1998 Oct 15; 92(8):2712-8. PubMed ID: 9763554
    [Abstract] [Full Text] [Related]

  • 16. Clinical characteristics and analysis of related factors associated with early death in newly diagnosed patients with acute promyelocytic leukemia.
    Wang A, Zhang Z, Zhu T, Liu X, Duan Q.
    Discov Oncol; 2024 Aug 27; 15(1):375. PubMed ID: 39192064
    [Abstract] [Full Text] [Related]

  • 17. Arsenic trioxide at conventional dosage does not aggravate hemorrhage in the first-line treatment of adult acute promyelocytic leukemia.
    Cui W, Wang J, Nie RM, Zhao LL, Gao MQ, Zhu HM, Chen L, Hu J, Li JM, Shen ZX, Wang ZY, Chen SJ, Chen Z, Wang KK, Xi XD, Mi JQ.
    Eur J Haematol; 2018 Apr 27; 100(4):344-350. PubMed ID: 29266395
    [Abstract] [Full Text] [Related]

  • 18. Combined therapy with all-trans-retinoic acid and high-dose chemotherapy in patients with hyperleukocytic acute promyelocytic leukemia and severe visceral hemorrhage.
    Dombret H, Sutton L, Duarte M, Daniel MT, Leblond V, Castaigne S, Degos L.
    Leukemia; 1992 Dec 27; 6(12):1237-42. PubMed ID: 1453767
    [Abstract] [Full Text] [Related]

  • 19. Successful treatment for multiple cerebral hemorrhage in a newly diagnosed patient with acute promyelocytic leukemia.
    Chung CY, Hsu NC, Horng HC, Chang CS.
    Leuk Lymphoma; 2003 Jun 27; 44(6):1059-61. PubMed ID: 12854910
    [Abstract] [Full Text] [Related]

  • 20. All-trans retinoic acid therapy in relapsed/refractory or newly diagnosed acute promyelocytic leukemia (APL) in Japan.
    Ohno R, Ohnishi K, Takeshita A, Tanimoto M, Murakami H, Kanamaru A, Asou N, Kobayashi T, Kuriyama K, Ohmoto E.
    Leukemia; 1994 Jun 27; 8 Suppl 3():S64-9. PubMed ID: 7808028
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.